{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T01:14:14Z","timestamp":1792890854927,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T00:00:00Z","timestamp":1534723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T00:00:00Z","timestamp":1534723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["K08 NS083626"],"award-info":[{"award-number":["K08 NS083626"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RG-14-188-01"],"award-info":[{"award-number":["RG-14-188-01"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"name":"B*CURED"},{"DOI":"10.13039\/100007886","name":"Dana-Farber Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 GM 7306-42"],"award-info":[{"award-number":["T32 GM 7306-42"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s11060-018-2978-2","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T10:10:49Z","timestamp":1534759849000},"page":"269-279","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Rapid discrimination of pediatric brain tumors by mass spectrometry imaging"],"prefix":"10.1007","volume":"140","author":[{"given":"Amanda R.","family":"Clark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Calligaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Regan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pomeranz Krummel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey N.","family":"Agar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Kallay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobey","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Schniederjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Santagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Pomeroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie Y. R.","family":"Agar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4577-1397","authenticated-orcid":false,"given":"Soma","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,20]]},"reference":[{"key":"2978_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/now207","author":"QT Ostrom","year":"2016","unstructured":"Ostrom QT, Gittleman H, Xu J et al (2016) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009\u20132013. Neuro Oncol. \n                    https:\/\/doi.org\/10.1093\/neuonc\/now207","journal-title":"Neuro Oncol"},{"key":"2978_CR2","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1001\/archneurpsyc.1925.02200140055002","volume":"14","author":"P Bailey","year":"1925","unstructured":"Bailey P, Cushing H (1925) Medulloblastoma cerebelli: a common type of midcerebellar glioma of childhood. Arch Neurol Psychiatry 14:192. \n                    https:\/\/doi.org\/10.1001\/archneurpsyc.1925.02200140055002","journal-title":"Arch Neurol Psychiatry"},{"key":"2978_CR3","unstructured":"Louis D, Ohgaki H, Wiestler O et al (2016) WHO classification of tumours of the central nervous system. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system, 4th edn. International Agency For Research On Cancer, Lyon Cedex 08, pp\u00a0184\u2013200"},{"key":"2978_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature22973","volume":"547","author":"PA Northcott","year":"2017","unstructured":"Northcott PA, Buchhalter I, Morrissy AS et al (2017) The whole-genome landscape of medulloblastoma subtypes. Nature 547:311\u2013317","journal-title":"Nature"},{"issue":"1","key":"2978_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1093\/neuonc\/now105","volume":"19","author":"DR Raleigh","year":"2017","unstructured":"Raleigh DR, Solomon DA, Lloyd SA et al (2017) Histopathologic review of pineal parenchymal tumors identifies novel morphologic subtypes and prognostic factors for outcome. Neuro-Oncology 19(1):78\u201388","journal-title":"Neuro-Oncology"},{"key":"2978_CR6","unstructured":"Louis DN, Ohgaki H, Wiestler OD et al (2016) WHO classification of tumours of the central nervous system. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system, 4th edn. International Agency For Research On Cancer, Lyon Cedex 08, pp\u00a0176\u2013179"},{"key":"2978_CR7","doi-asserted-by":"publisher","first-page":"490","DOI":"10.12688\/f1000research.10859.1","volume":"6","author":"S Sengupta","year":"2017","unstructured":"Sengupta S, Pomeranz Krummel D, Pomeroy S (2017) The evolution of medulloblastoma therapy to personalized medicine. F1000Research 6:490. \n                    https:\/\/doi.org\/10.12688\/f1000research.10859.1","journal-title":"F1000Research"},{"key":"2978_CR8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.nec.2011.05.003","volume":"22","author":"EJ Fontana","year":"2011","unstructured":"Fontana EJ, Garvin J, Feldstein N, Anderson RCE (2011) Pediatric considerations for pineal tumor management. Neurosurg Clin N Am 22:395\u2013402","journal-title":"Neurosurg Clin N Am"},{"key":"2978_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-017-0363-1","author":"K Misawa","year":"2017","unstructured":"Misawa K, Mochizuki D, Imai A et al (2017) Epigenetic silencing of SALL3 is an independent predictor of poor survival in head and neck cancer. Clin Epigenetics. \n                    https:\/\/doi.org\/10.1186\/s13148-017-0363-1","journal-title":"Clin Epigenetics"},{"key":"2978_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1010428317691189","volume":"39","author":"T Vallius","year":"2017","unstructured":"Vallius T, Hynninen J, Auranen A et al (2017) Postoperative human epididymis protein 4 predicts primary therapy outcome in advanced epithelial ovarian cancer. Tumor Biol 39:1\u20138. \n                    https:\/\/doi.org\/10.1177\/1010428317691189","journal-title":"Tumor Biol"},{"key":"2978_CR11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2013.05.017","volume":"18","author":"E Currie","year":"2013","unstructured":"Currie E, Schulze A, Zechner R et al (2013) Cellular fatty acid metabolism and cancer. Cell Metab 18:153\u2013161","journal-title":"Cell Metab"},{"issue":"1","key":"2978_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12943-017-0646-3","volume":"16","author":"X Luo","year":"2017","unstructured":"Luo X, Cheng C, Tan Z et al (2017) Emerging roles of lipid metabolism in cancer metastasis. Mol Cancer 16(1):76","journal-title":"Mol Cancer"},{"key":"2978_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/febs.14281","author":"U Ray","year":"2017","unstructured":"Ray U, Roy SS (2017) Aberrant lipid metabolism in cancer cells\u2014the role of oncolipid-activated signaling. FEBS J. \n                    https:\/\/doi.org\/10.1111\/febs.14281","journal-title":"FEBS J"},{"key":"2978_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2017.00325","author":"MC Fernandes Messias","year":"2018","unstructured":"Fernandes Messias MC, Mecatti GC, Figueiredo Angolini CF et al (2018) Plasma lipidomic signature of rectal adenocarcinoma reveals potential biomarkers. Front Oncol. \n                    https:\/\/doi.org\/10.3389\/fonc.2017.00325","journal-title":"Front Oncol"},{"key":"2978_CR15","doi-asserted-by":"publisher","first-page":"13231","DOI":"10.18632\/oncotarget.24229","volume":"9","author":"MY Lee","year":"2018","unstructured":"Lee MY, Yeon A, Shahid M et al (2018) Reprogrammed lipid metabolism in bladder cancer with cisplatin resistance. Oncotarget 9:13231\u201313243. \n                    https:\/\/doi.org\/10.18632\/oncotarget.24229","journal-title":"Oncotarget"},{"key":"2978_CR16","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1007\/s10529-017-2417-z","volume":"39","author":"N Jiang","year":"2017","unstructured":"Jiang N, Zhang G, Pan L et al (2017) Potential plasma lipid biomarkers in early-stage breast cancer. Biotechnol Lett 39:1657\u20131666. \n                    https:\/\/doi.org\/10.1007\/s10529-017-2417-z","journal-title":"Biotechnol Lett"},{"key":"2978_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2017.06.006","author":"DJ Stephenson","year":"2017","unstructured":"Stephenson DJ, Alexis Hoeferlin L, Chalfant Richmond CE (2017) Lipidomics in translational research and the clinical significance of lipid-based biomarkers. Transl Res. \n                    https:\/\/doi.org\/10.1016\/j.trsl.2017.06.006","journal-title":"Transl Res"},{"key":"2978_CR18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1749-6632.2000.tb06554.x","volume":"905","author":"Y Xiao","year":"2000","unstructured":"Xiao Y, Chen Y, Kennedy a W et al (2000) Evaluation of plasma lysophospholipids for diagnostic significance using electrospray ionization mass spectrometry (ESI-MS) analyses. Ann N Y Acad Sci 905:242\u2013259. \n                    https:\/\/doi.org\/10.1111\/j.1749-6632.2000.tb06554.x","journal-title":"Ann N Y Acad Sci"},{"key":"2978_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/srep20984","author":"J Li","year":"2016","unstructured":"Li J, Ren S, Piao H et al (2016) Integration of lipidomics and transcriptomics unravels aberrant lipid metabolism and defines cholesteryl oleate as potential biomarker of prostate cancer. Sci Rep. \n                    https:\/\/doi.org\/10.1038\/srep20984","journal-title":"Sci Rep"},{"key":"2978_CR20","doi-asserted-by":"publisher","first-page":"4608","DOI":"10.1158\/0008-5472.CAN-15-3403","volume":"76","author":"Z Hall","year":"2016","unstructured":"Hall Z, Ament Z, Wilson CH et al (2016) MYC expression drives aberrant lipid metabolism in lung cancer. Cancer Res 76:4608\u20134618. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-3403","journal-title":"Cancer Res"},{"key":"2978_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-9-186","author":"Y Liu","year":"2010","unstructured":"Liu Y, Chen Y, Momin A et al (2010) Elevation of sulfatides in ovarian cancer: an integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry. Mol Cancer. \n                    https:\/\/doi.org\/10.1186\/1476-4598-9-186","journal-title":"Mol Cancer"},{"key":"2978_CR22","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.bbalip.2011.03.004","volume":"1811","author":"N Goto-Inoue","year":"2011","unstructured":"Goto-Inoue N, Hayasaka T, Zaima N, Setou M (2011) Imaging mass spectrometry for lipidomics. Biochim Biophys Acta 1811:961\u2013969. \n                    https:\/\/doi.org\/10.1016\/j.bbalip.2011.03.004","journal-title":"Biochim Biophys Acta"},{"key":"2978_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-00703-w","volume":"7","author":"M Dilillo","year":"2017","unstructured":"Dilillo M, Ait-Belkacem R, Esteve C et al (2017) Ultra-high mass resolution MALDI imaging mass spectrometry of proteins and metabolites in a mouse model of glioblastoma. Sci Rep 7:1\u201311. \n                    https:\/\/doi.org\/10.1038\/s41598-017-00703-w","journal-title":"Sci Rep"},{"key":"2978_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep36814","volume":"6","author":"NH Patterson","year":"2016","unstructured":"Patterson NH, Alabdulkarim B, Lazaris A et al (2016) Assessment of pathological response to therapy using lipid mass spectrometry imaging. Sci Rep 6:1\u201313. \n                    https:\/\/doi.org\/10.1038\/srep36814","journal-title":"Sci Rep"},{"key":"2978_CR25","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/bs.acr.2016.11.010","volume":"134","author":"LA McDonnell","year":"2017","unstructured":"McDonnell LA, Angel PM, Lou S, Drake RR (2017) Mass spectrometry imaging in cancer research: future perspectives. Adv Cancer Res 134:283\u2013290. \n                    https:\/\/doi.org\/10.1016\/bs.acr.2016.11.010","journal-title":"Adv Cancer Res"},{"key":"2978_CR26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature11329","volume":"488","author":"TJ Pugh","year":"2012","unstructured":"Pugh TJ, Weeraratne SD, Archer TC et al (2012) Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 488:106\u2013110. \n                    https:\/\/doi.org\/10.1038\/nature11329","journal-title":"Nature"},{"key":"2978_CR27","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/nar\/gkl838","volume":"35","author":"M Sud","year":"2007","unstructured":"Sud M, Fahy E, Cotter D et al (2007) LMSD: LIPID MAPS structure database. Nucleic Acids Res 35:527\u2013532. \n                    https:\/\/doi.org\/10.1093\/nar\/gkl838","journal-title":"Nucleic Acids Res"},{"key":"2978_CR28","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1158\/0008-5472.CAN-11-2465","volume":"72","author":"LS Eberlin","year":"2012","unstructured":"Eberlin LS, Norton I, Dill AL et al (2012) Classifying human brain tumors by lipid imaging with mass spectrometry. Cancer Res 72:645\u2013654. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-2465","journal-title":"Cancer Res"},{"key":"2978_CR29","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/jms.3295","volume":"48","author":"D Calligaris","year":"2013","unstructured":"Calligaris D, Norton I, Feldman DR et al (2013) Mass spectrometry imaging as a tool for surgical decision-making. J Mass Spectrom 48:1178\u20131187. \n                    https:\/\/doi.org\/10.1002\/jms.3295","journal-title":"J Mass Spectrom"},{"key":"2978_CR30","doi-asserted-by":"publisher","first-page":"11121","DOI":"10.1073\/pnas.1404724111","volume":"111","author":"S Santagata","year":"2014","unstructured":"Santagata S, Eberlin LS, Norton I et al (2014) Intraoperative mass spectrometry mapping of an onco-metabolite to guide brain tumor surgery. Proc Natl Acad Sci USA 111:11121\u201311126. \n                    https:\/\/doi.org\/10.1073\/pnas.1404724111","journal-title":"Proc Natl Acad Sci USA"},{"key":"2978_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-017-0442-y","author":"R Blassberg","year":"2017","unstructured":"Blassberg R, Jacob J (2017) Lipid metabolism fattens up hedgehog signaling. BMC Biol. \n                    https:\/\/doi.org\/10.1186\/s12915-017-0442-y","journal-title":"BMC Biol"},{"key":"2978_CR32","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.celrep.2015.01.058","volume":"10","author":"J Long","year":"2015","unstructured":"Long J, Tokhunts R, Old WM et al (2015) Identification of a family of fatty-acid-speciated sonic hedgehog proteins, whose members display differential biological properties. Cell Rep 10:1280\u20131287. \n                    https:\/\/doi.org\/10.1016\/j.celrep.2015.01.058","journal-title":"Cell Rep"},{"key":"2978_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20091866","volume":"427","author":"JK Sethi","year":"2010","unstructured":"Sethi JK, Vidal-Puig A (2010) Wnt signalling and the control of cellular metabolism. Biochem J 427:1\u201317. \n                    https:\/\/doi.org\/10.1042\/BJ20091866","journal-title":"Biochem J"},{"key":"2978_CR34","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1038\/oncsis.2015.49","volume":"5","author":"S Beloribi-Djefaflia","year":"2016","unstructured":"Beloribi-Djefaflia S, Vasseur S, Guillaumond F (2016) Lipid metabolic reprogramming in cancer cells. Oncogenesis 5:e189. \n                    https:\/\/doi.org\/10.1038\/oncsis.2015.49","journal-title":"Oncogenesis"},{"key":"2978_CR35","doi-asserted-by":"publisher","first-page":"8408","DOI":"10.1073\/pnas.0602852103","volume":"103","author":"RB Corcoran","year":"2006","unstructured":"Corcoran RB, Scott MP (2006) Oxysterols stimulate Sonic hedgehog signal transduction and proliferation of medulloblastoma cells. Proc Natl Acad Sci USA 103:8408\u20138413. \n                    https:\/\/doi.org\/10.1073\/pnas.0602852103","journal-title":"Proc Natl Acad Sci USA"},{"key":"2978_CR36","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1158\/0008-5472.CAN-12-0006","volume":"72","author":"SY Lee","year":"2012","unstructured":"Lee SY, Jeon HM, Ju MK et al (2012) Wnt\/snail signaling regulates cytochrome c oxidase and glucose metabolism. Cancer Res 72:3607\u20133617. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-0006","journal-title":"Cancer Res"},{"key":"2978_CR37","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1093\/carcin\/bgt390","volume":"35","author":"V Sherwood","year":"2014","unstructured":"Sherwood V, Chaurasiya SK, Ekstr\u00f6m EJ et al (2014) WNT5A-mediated \u00df-catenin-independent signalling is a novel regulator of cancer cell metabolism. Carcinogenesis 35:784\u2013794. \n                    https:\/\/doi.org\/10.1093\/carcin\/bgt390","journal-title":"Carcinogenesis"},{"key":"2978_CR38","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/1471-2407-14-124","volume":"14","author":"L Yang","year":"2014","unstructured":"Yang L, Perez AA, Fujie S et al (2014) Wnt modulates MCL1 to control cell survival in triple negative breast cancer. BMC Cancer 14:124. \n                    https:\/\/doi.org\/10.1186\/1471-2407-14-124","journal-title":"BMC Cancer"},{"key":"2978_CR39","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.15252\/embj.201488598","volume":"33","author":"KT Pate","year":"2014","unstructured":"Pate KT, Stringari C, Sprowl-Tanio S et al (2014) Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer. EMBO J 33:1454\u20131473. \n                    https:\/\/doi.org\/10.15252\/embj.201488598","journal-title":"EMBO J"},{"key":"2978_CR40","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1007\/s13361-015-1131-0","volume":"26","author":"L Xu","year":"2015","unstructured":"Xu L, Kliman M, Forsythe JG et al (2015) Profiling and imaging ion mobility-mass spectrometry analysis of cholesterol and 7-dehydrocholesterol in cells via sputtered silver MALDI. J Am Soc Mass Spectrom 26:924\u2013933. \n                    https:\/\/doi.org\/10.1007\/s13361-015-1131-0","journal-title":"J Am Soc Mass Spectrom"},{"key":"2978_CR41","doi-asserted-by":"publisher","first-page":"11336","DOI":"10.18632\/oncotarget.24168","volume":"9","author":"SE Kohe","year":"2018","unstructured":"Kohe SE, Bennett CD, Gill SK et al (2018) Metabolic profiling of the three neural derived embryonal pediatric tumors retinoblastoma, neuroblastoma and medulloblastoma, identifies distinct metabolic profiles. Oncotarget 9:11336\u201311351. \n                    https:\/\/doi.org\/10.18632\/oncotarget.24168","journal-title":"Oncotarget"},{"key":"2978_CR42","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3390\/metabo3041084","volume":"3","author":"A Hutschenreuther","year":"2013","unstructured":"Hutschenreuther A, Birkenmeier G, Bigl M et al (2013) Glycerophosphoglycerol, beta-alanine, and pantothenic acid as metabolic companions of glycolytic activity and cell migration in breast cancer cell lines. Metabolites 3:1084\u20131101. \n                    https:\/\/doi.org\/10.3390\/metabo3041084","journal-title":"Metabolites"},{"key":"2978_CR43","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.2217\/fon.10.116","volume":"6","author":"S Ponnusamy","year":"2010","unstructured":"Ponnusamy S, Meyers-Needham M, Senkal CE et al (2010) Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance. Futur Oncol 6:1603\u20131624. \n                    https:\/\/doi.org\/10.2217\/fon.10.116","journal-title":"Futur Oncol"},{"key":"2978_CR44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrc.2017.96","volume":"18","author":"B Ogretmen","year":"2017","unstructured":"Ogretmen B (2017) Sphingolipid metabolism in cancer signalling and therapy. Nat Rev Cancer 18:33\u201350","journal-title":"Nat Rev Cancer"},{"key":"2978_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.7379","author":"N Ogrinc Poto\u010dnik","year":"2015","unstructured":"Ogrinc Poto\u010dnik N, Porta T, Becker M et al (2015) Use of advantageous, volatile matrices enabled by next-generation high-speed matrix-assisted laser desorption\/ionization time-of-flight imaging employing a scanning laser beam. Rapid Commun Mass Spectrom. \n                    https:\/\/doi.org\/10.1002\/rcm.7379","journal-title":"Rapid Commun Mass Spectrom"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-018-2978-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-018-2978-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-018-2978-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T07:31:43Z","timestamp":1589700703000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-018-2978-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,20]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["2978"],"URL":"https:\/\/doi.org\/10.1007\/s11060-018-2978-2","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,20]]},"assertion":[{"value":"28 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare they have no conflict of interest with the present study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}